Everett Vokes to Alkyl and Aryl Transferases
This is a "connection" page, showing publications Everett Vokes has written about Alkyl and Aryl Transferases.
Connection Strength
0.253
-
Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting. Lung Cancer. 2003 Aug; 41 Suppl 1:S115-21.
Score: 0.203
-
Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2003 May 01; 21(9):1760-6.
Score: 0.050